Viewing StudyNCT01561911



Ignite Creation Date: 2024-05-06 @ 12:24 AM
Last Modification Date: 2024-10-26 @ 10:49 AM
Study NCT ID: NCT01561911
Status: COMPLETED
Last Update Posted: 2014-12-02
First Post: 2012-03-21

Brief Title: A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 74 to Treat Advanced Malignancies Refractory to Conventional Anti-cancer Treatment
Sponsor: Cancer Research UK
Organization: Cancer Research UK

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-07
Start Date Type: None
Primary Completion Date: 2014-10
Primary Completion Date Type: ACTUAL
Completion Date: 2014-10
Completion Date Type: ACTUAL
First Submit Date: 2012-03-21
First Submit QC Date: March 22 2012
Study First Post Date: 2012-03-23
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-12-01
Last Update Post Date: 2014-12-02
Last Update Post Date Type: ESTIMATED